People with thyroid eye disease receiving infusions of the insulin-like growth factor-1 receptor veligrotug report improved quality of life after 15 weeks of treatment. Medscape Medical News
Uncategorized
Epi-on cross-linking with oxygen shows efficacy, safety
ORLANDO — Epithelium-on cross-linking with oxygen supplementation showed efficacy, safety and speed as a treatment for keratoconus, according to a poster presentation.At the American Academy of Ophthalmology meeting, Kenneth A. Beckman, MD, FACS, of Co…
Uncategorized
Global Healthy Living Foundation Leads Nationwide Recognition of Giant Cell Arteritis Awareness Day on October 23
UPPER NYACK, N.Y.–(BUSINESS WIRE)– #arthritis–Giant Cell Arteritis, an inflammatory blood vessel condition, gets recognition day October 23
Uncategorized
Q&A: JAMA launches women’s health digital curation
JAMA and the JAMA Network launched a new resource centered entirely on women’s health, consolidating the high-quality research from across the network.The digital curation will “showcase rigorous studies that include or focus exclusively on women” from…
Uncategorized
Drop adherence, cost among top pain points for glaucoma treatment
ORLANDO — Glaucoma therapies have come a long way, but pain points still remain, according to a speaker at the American Academy of Ophthalmology meeting.Ruth D. Williams, MD, of Wheaton Eye Clinic in Illinois, said when she started practicing, she had …
Uncategorized
Foster Grant Releases New Wicked: For Good – Inspired Eyewear
SMITHFIELD, R.I.–(BUSINESS WIRE)–Foster Grant, one of the world’s leading over-the-counter eyewear brands, has unveiled the second installment of its Wicked x Foster Grant collection, ahead of the upcoming release of Universal Pictures’ epic conclusi…